Pharma stocks are popular with investors because they maintain stable margins regardless of economic cycles, thanks to consistent product demand. The pharma industry's outlook appears bright due to the rising number of chronic diseases, an aging population, the adoption of AI in drug manufacturing, and higher R&D investments for both common and rare conditions.
Amid this backdrop, investors could consider buying fundamentally strong pharma stocks: Collegium Pharmaceutical, Inc. (COLL), Novo Nordisk A/S (NVO), and GSK plc (GSK).
